Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II MA-5 trial in mitochondrial disease with hearing loss
jRCT2031250505Phase 2Active, not recruiting
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of MA-5 in Mitochondriopathy (3 arms). Started Dec 2025; status: active, not recruiting.
02
Drugs
MA-5
03
Conditions
Mitochondriopathy
Beyond the preview
Go deeper on jRCT2031250505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250505.